Some Medicare Advantage plans (Medicare Part C) and some Medicare Part D prescription drug plans may cover other cannabinoid-based medications, however. Cannabinoids are types of chemicals that are found in marijuana.
More than 31 states allowing the use of marijuana for medicinal purposes in 2018.1 So what does this mean for your coverage options as a Medicare beneficiary?
Learn more in this guide about how a Medicare Advantage plan could help cover the cannabinoids you need.
Though some Medicare Advantage plans and some Medicare Part D plans may cover cannabinoid-based medications, Original Medicare (Medicare Part A and Part B) does not.
The biggest reason why medical marijuana is not covered by Original Medicare is that marijuana is not approved for medicinal use by the Food and Drug Administration (FDA).
A second reason is because marijuana remains federally classified as a Schedule I drug, meaning it is not recognized by the federal government as having any medicinal value.
Dronabinol is a synthetic form of cannabis that is used to treat the loss of appetite and weight loss suffered by some people with AIDS, Dronabinol can also be used to help treat the nausea and vomiting associated with cancer chemotherapy.
Dronabinol is the active ingredient in brand name drugs Syndros and Marinol, and both drugs may be covered by some Medicare Advantage plans with prescription drug coverage as well as some Medicare Part D plans.
Syndros comes in a liquid form while Marinol comes in the form of a gel capsule. Dronabinol also comes in capsule form as a generic drug that may also be covered by some Medicare Advantage plans and Medicare Part D plans.
Syndros and Marinol are both approved by the FDA and are both classified as Schedule II drugs.2 This category features drugs with accepted medicinal use that are considered to carry a high risk of addiction or abuse and includes such drugs as oxycodone, fentanyl, morphine and methadone.
Check with your Medicare Advantage or Medicare Prescription Drug Plan carrier to determine if this type of medication (or any others you may need) is included in your plan’s formulary. A formulary is a plan’s list of covered medications.
The average retail price of 60 capsules of Dronabinol is reported to be $257.3 A Medicare Advantage plan or a Medicare Part D plan that covers Dronabinol could help alleviate some of that cost.
Medicare Advantage and Part D plans are sold by private insurance companies, so premiums, deductibles and coinsurance amounts can vary from one plan to the next.
Are you looking to find a Medicare Advantage plan that covers prescription drugs, such as cannabinoids that are similar to medical marijuana?
Not all plans in all locations offer the same benefits, so it can help to work with a licensed insurance agent to find out more about the plans that are available where you live.
Explore Medicare Advantage plan benefits in your areaCompare plans now
Or call 1-800-557-6059 (TTY: 711) 24/7 to speak with a licensed insurance agent.
1 National Conference of State Legislatures. State Medical Marijuana Laws. (Nov. 8, 2018). Retrieved from www.ncsl.org/research/health/state-medical-marijuana-laws.aspx.
2 Ellis, Lisa. FDA Approves Syndros, First Liquid Form of Cannabinoid Dronabinol. (Aug. 9, 2017). Practical Pain Management. Retrieved from www.practicalpainmanagement.com/resources/news-and-research/fda-approves-syndros-first-liquid-form-cannabinoid-dronabinol.
3 GoodRx. Donabinol. Retrieved Nov. 9, 2018 from www.goodrx.com/dronabinol.
Copyright © 2019 TZ Insurance Solutions LLC. All rights reserved.
MedicareAdvantage.com is a website owned and operated by TZ Insurance Solutions LLC. TZ Insurance Solutions LLC and TruBridge, Inc. represent Medicare Advantage Organizations and Prescription Drug Plans having Medicare contracts; enrollment in any plan depends upon contract renewal.
Plan availability varies by region and state. For a complete list of available plans, please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
Medicare has neither reviewed nor endorsed this information.